patients underwent thyroid or neck US examination, performed by 2 radiologists, at our center. On the basis of real-time US, the presence or absence of TGDCs was prospectively investigated by 2 radiologists. Among the 2820 patients, 54 patients who were <19 years of age or had a radiation therapy history to the neck were excluded. Eventually, 2766 patients were included.
Comparison of Prevalence and Ultrasonography Features of Thyroglossal Duct Cyst in Adults
According to Radioactive Iodine Ablation CDE 1 Yoo Jin Lee ABCDE 
Background
Thyroglossal duct cyst (TGDC) is the most common congenital abnormality in the neck, accounting for 70-75% of midline neck masses [1] [2] [3] . TGDCs are originated from remnants of the thyroglossal duct after the thyroid gland migrates from the foramen cecum to its final site in the anterior lower neck [1] [2] [3] [4] [5] . In general, the thyroglossal duct disappears by the 8 th to 10 th week of gestation, but the persistent secretory epithelium may form a cyst when it fails to completely involute [4] . TGDCs are typically located near the hyoid bone and thyrohyoid membrane [1, 2] . High-resolution ultrasonography (US) is a useful tool in the diagnosis and management of neuromuscular pathology and abnormalities in the surrounding structures [6] . On US, TGDCs are usually observed as thin-walled, unilocular, anechoic cystic masses with posterior enhancement [5] . Enlargement of TGDCs is a well-documented finding after an infection [1] [2] [3] .
Several investigators have reported enlargement of TGDCs after radiation therapy [5, 6] . They suggested that repeated inflammation due to radiation therapy may have caused an undetected, subclinical thyroglossal duct to secrete fluid and/or to obstruct the duct, thereby causing it to manifest as a cystic mass [5, 7] . However, the relationship between TGDCs and radiation therapy is still unclear. Furthermore, cystic enlargement of a neck mass or a new cystic lesion should be differentiated from cystic metastasis of thyroid cancer or other head and neck cancer [1, 8] . To our knowledge, no previous studies have determined the association between TGDCs and radioactive iodine ablation (RIA), nor have they investigated the prevalence and US features of TGDCs according to whether RIA was performed in adults. Therefore, this study aimed to assess the prevalence of TGDCs on US and US features of TGDCs in adults, and to assess whether the prevalence or size of TGDCs increases after RIA.
Material and Methods

Study population
The Busan Paik Hospital Institutional review board approved this study (IRB 18-0056), and they waived written informed consent. Between July and December 2018, 2820 patients (2176 female and 644 male patients, mean age ± standard deviation (SD): 52.6±13.3 years; age range: 1-91 years) underwent thyroid or neck US examination at the Thyroid and Head & Neck Cancer center of our hospital. Among them, 54 patients (28 female and 26 male patients, mean age±SD: 10.5±10.7 years; age range: 1-58 years) were excluded owing to young age (<19 years; n=52) and a history of radiation therapy to the neck (n=2). Eventually, 2766 patients (2148 women and 618 men, mean age±SD: 53.4±11.9 years, age range: 19-91 years) were included.
Ultrasonographic examination and image analysis
US examination was done using a high-resolution ultrasound scanner (iU 22, Philips Medical Systems, Bothell, WA, USA; and Aplio 400, Toshiba Medical Systems, Tokyo, Japan) with a 5-12-MHz linear probe by 2 experienced radiologists (with 7 and 16 years of experience, respectively, in performing thyroid or neck US). The patients were randomly allocated to be examined by either one of 2 US instruments. Both the radiologists prospectively investigated the midline neck from the tongue base to the thyroid isthmus on real-time US during the study period. Only one radiologist performed thyroid or neck US for each patient.
On US, TGDCs were defined as thin-walled, anechoic cystic lesions with posterior enhancement in the anterior upper midline neck when it could be differentiated from adjacent muscular or vascular structures. In addition, when the cystic lesion showed atypical content owing to the proteinaceous material or hemorrhage, it was considered as a TGDC [3, 5] . The presence or absence, location, largest diameter, and shape of the TGDCs were investigated. The location of TGDCs was divided into the suprahyoid or infrahyoid neck level by the hyoid bone. When a TGDC was located in both the suprahyoid and infrahyoid neck levels, the location was determined according to which level included the greater component of the TGDC. The shape of the TGDC was classified into flat-to-ovoid, round, amorphous, or tubular (longitudinally arranged).
Radioactive iodine ablation
In our hospital, the RIA dose was determined depending on the patient's clinical status, and in patients with papillary thyroid carcinoma, the RIA dose was ranged from 1.11 to 7.4 GBq (30-200 mCi) for the complete removal of remnant cancer after total thyroidectomy [9] . The presence or absence of RIA therapy, the number of RIA sessions, and the highest dose of RIA were evaluated in all patients.
Statistical analysis
The data were analyzed for normal distribution by using the Kolmogorov-Smirnov test. Normally distributed variables were expressed as the mean±SD and compared by the independent t-test. Group comparisons of categorical variables were tested by the c 2 test or, for small cell values, the Fisher's exact test. Spearman correlation analysis was used to evaluate the relation between the maximum dose of RIA and size of TGDC. All statistical analyses were conducted using SPSS, Version 24.0 (IBM, Armonk, New York). A p value of <0.05 was statistically significant. The comparison of clinical and US findings of TGDCs for 160 patients according to RIA application is shown in Table 3 . There were no significant differences in patient age and gender; radiologists; and location, size, and shape of TGDCs between the RIA application and non-application groups (p>0.05). Moreover, no significant correlation was observed between the maximum dose and size of TGDCs (rho=0.084, p=0.293).
The comparison of clinical and US findings of TGDCs for 160 patients according to the 2 investigators is shown in Table 4 . Of the 160 patients, the location of TGDCs was the suprahyoid neck (77.5%) ( Figure 1 ) and infrahyoid neck (22.5%) ( Figure 2 ). 
Discussion
In the present study, we assessed whether there was a difference in the prevalence of TGDCs according to RIA application. However, there was no significant difference in the session number of RIA or history of RIA between the TGDC (+) and TGDC (-) groups. In addition, the mean size of TGDCs was 0.9 cm, and there was no significant relationship between size of TGDCs and RIA. In the previous studies [5, 7] , radiation therapy may be associated with enlargement of TGDCs. The reason for this difference is unclear, but the following factors can be considered. Our study included patients who underwent RIA, whereas previous studies evaluated those who underwent radiation therapy. In the previous studies on radiation therapy, all the TGDCs were observed to be large on the immediate post-therapeutic computed tomography scan after radiation (interval ranging from 4 to 14 weeks after completion of radiation therapy) [7] . All TGDCs became smaller and less conspicuous over time because inflammatory changes had long since resolved [7] . However, in our study, we did not evaluate interval change of TGDCs. Furthermore, our study made indirect comparisons regarding the prevalence of TGDCs according to whether RIA was performed. For a more accurate evaluation of the relationship between the presence of TGDCs and the application of RIA, a direct comparison using US before and after RIA may be required. Further studies are required to clarify this issue.
In previous cadaveric studies, the prevalence rate of TGDCs was 7-15% [10, 11] . In our study, the prevalence rate of TGDCs was 5.8% (160/2766), which was similar or lower than the rate in the previous cadaveric studies [10, 11] . The reason for the lower rate may be associated with the use of different detection methods. Moreover, in our study, the prevalence rate of TGDCs was different for both radiologists. The reason for this difference may be associated with the inclusion of heterogeneous study patients, including differences in patient age, gender, reason for thyroid/neck US, type of thyroid surgery, and number of RIA sessions and whether RIA was performed.
In addition, interobserver variability should be considered. However, we could not calculate interobserver variability because both radiologists did not investigate TGDCs in the same patients by using US.
The typical US features of TGDCs include thin-walled, unilocular, anechoic cystic masses with posterior enhancement [1, 2, 5] .
In our study, all TGDCs showed typical US features. TGDCs are found in varying locations across studies [5, [12] [13] [14] . In our study, most TGDCs were located in the suprahyoid neck (77.5%).
Regarding the shape of TGDCs, our study findings were similar to those obtained in a recent US study of TGDCs that reported a round/ovoid shape (56%) [15] . In our study, there was no difference in the location or shape of TGDCs between the 2 radiologists. 
